Stock Rich List
#4735 on the rich list of 14,644 insiders

Robert E. Landry

EVP Finance CFO at Regeneron Pharmaceuticals; Director at Cytokinetics. Based in South San Francisco, California.

$22.6M
in disclosed stock, −$467K (−2.02%) today
Live prices, last trade 3:17 PM ET
Rank
4735th of 14,644
Companies held
2
Largest holding
REGN, 98.1% of total
Latest SEC filing
Sep 15, 2026

What the $22.6M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Regeneron Pharmaceuticals REGN
Common Stock
Directly23,693$925.99$21.9M97.0%Form 4, Feb 2, 2024
Cytokinetics CYTK
Common Stock
Directly8,184$51.53$422K1.9%Form 4, Sep 15, 2026
Regeneron Pharmaceuticals REGN
Common Stock
Through 401(k) Plan270$925.99$250K1.1%Form 4, Feb 2, 2024

Share counts are the amounts Robert E. Landry reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 15, 2026SoldCYTK1,000$72.13$72KView
Sep 11, 2026SoldCYTK1,000$74.66$75KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
4732Matthew Krueger
CFO, Treasurer and Secretary, Strive. Dallas, TX
$22.6M−$57K (−0.25%)
4733Scott McFeely
SVP, Networking Platforms, Ciena. Hanover, MD
$22.6M−$50K (−0.22%)
4734Jan Gommaar M. Vleugels
COO - INTERNATIONAL, Alliance Laundry Holdings. Ripon, WI
$22.6M−$312K (−1.36%)
4735Robert E. Landry
EVP Finance CFO, Regeneron Pharmaceuticals. South San Francisco, CA
$22.6M−$467K (−2.02%)
4736Mark V Anquillare
Group President and COO, Verisk Analytics. San Mateo, CA
$22.6M−$167K (−0.73%)
4737Sara Yang Bosco
Sr VP, Secy & Chf Leg Ofc, Emerson Electric. St. Louis, MO
$22.6M−$562K (−2.43%)
4738Michael Tabor
10% owner, iHeartMedia
$22.6M−$3.2M (−12.55%)

Other Regeneron Pharmaceuticals insiders

All REGN insiders

Questions

How much stock does Robert E. Landry own?

Robert E. Landry holds $22,611,220 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 4735th on the Stock Rich List.

Is this Robert E. Landry's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Robert E. Landry last buy or sell stock?

The most recent open-market trade on file is a sale of 1,000 CYTK shares on Sep 15, 2026 at $72.13.